Skip to content
Screener

SpaceX SPCX Cash & Equivalents

Cash & Equivalents at other companies

U.S. Bancorp logo
U.S. BancorpUSB
$48.42B-3.2%
BK
BKBK
$9.49B+12.8%
Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX
$3.08M+1,132%
Veradermics
 logo
Veradermics MANE
$168.41M+419%
Schering-Plough logo
Schering-PloughSGP
$238.9M+312%
Curtiss-Wright logo
Curtiss-WrightCW
$343.45M+51.7%

Other financials

Income statement

See full
Revenue$7.8B+91.9%
Gross profit$4.3B+141%
Operating income-$143.0M+85.3%
Net income-$541.0M+46.3%
EPS (diluted)-$0.09+73.5%

Balance sheet

See full
Total debt$40.8B
Total equity$127.22B+2,339%
Total assets$192.77B

Valuation

See full
Market cap$1.43T-32.2%
Enterprise value$1.37T

Returns & leverage

See full
Debt / equity0.3×
Current ratio5.1×

Where this comes from

Reported directly by SpaceX in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: SpaceX’s 10-Q, filed August 4, 2026. Open the filing →

Filed
Aug 4, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-052535

FAQ

What is SpaceX's cash & equivalents?
SpaceX (SPCX) reported cash & equivalents of $93.52B in Q2 2026.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about SpaceX's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude